Artgen Biotech took part in one of the key events of the year in the world of Russian technologies — Startup Village 2025 International Conference held on May 29 and 30 at Skolkovo Innovation Center.
This hallmark event brings together the country's technological leaders, promising startups and residents of Skolkovo, Moscow Innovation Cluster, Medtech and other industry associations to demonstrate cutting-edge achievements.
Artgen Biotech occupied an honorable place in the Central Pavilion called “Technological Leaders” and presented a portfolio of its developments used in practical healthcare, including: Neovasculgen, Genetico systems for genetic testing, Gistograft osteoplastic material.
The key event was the visit of Dmitriy Anatolyevich Medvedev, Deputy Chairman of the Security Council of the Russian Federation, to Artgen Biotech's exposition. This visit highlights the significance of the company's developments.
Sergey Masyuk, Artgen Biotech's Director, personally presented to Dmitriy Anatolyevich the company's advanced achievements aimed at enhancing the quality of healthcare and efficient management of socially significant and orphan diseases.